NAV5/24/2017 Chg.+3.3900 Type of yield Investment Focus Investment company
538.1200EUR +0.63% reinvestment Equity Worldwide Bellevue Asset Mgmt. 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2009 - - - - -2.45 6.30 6.58 -0.94 3.24 -11.67 4.98 5.10 -
2010 4.70 4.84 5.87 0.14 -4.99 -3.21 -3.09 0.49 4.34 4.57 1.80 4.34 +20.78%
2011 -4.93 -0.52 -1.71 3.48 3.28 -1.57 -1.16 -13.41 -0.17 1.99 4.08 6.82 -5.27%
2012 12.52 -0.44 3.83 1.03 6.49 1.14 7.03 -0.33 3.59 -9.18 4.64 -1.86 +30.44%
2013 4.47 5.61 9.77 6.55 4.77 -4.15 12.35 -2.03 6.33 -3.56 8.10 -0.15 +57.85%
2014 12.43 4.14 -10.65 -4.57 4.54 8.21 1.21 13.15 3.08 11.08 3.16 2.38 +56.40%
2015 15.76 6.41 5.03 -7.83 12.31 -1.95 2.94 -12.77 -11.98 10.68 7.11 -1.84 +20.78%
2016 -22.77 -5.53 -0.31 3.53 6.38 -9.16 12.51 -2.37 2.05 -11.83 12.41 -3.35 -21.86%
2017 4.94 9.09 -1.11 -0.06 -4.22 - - - - - - - -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 18.68% 19.97% 24.90% 29.81% 27.00%
Sharpe ratio 1.26 0.07 0.36 0.52 0.80
Best month +9.09% +12.41% +12.51% +15.76% +15.76%
Worst month -4.22% -4.22% -11.83% -22.77% -22.77%
Maximum loss -8.25% -8.35% -19.80% -44.14% -44.14%
Outperformance +1.15% - +0.70% +9.16% +31.28%
 
All quotes in EUR

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
BB Adamant Biotech I USD reinvestment 449.3500 +8.97% +25.43%
BB Adamant Biotech I EUR reinvestment 538.1200 +8.74% +52.68%
BB Adamant Biotech I CHF reinvestment 386.8500 +7.24% +36.46%
BB Adamant Biotech I GBP reinvestment 366.7300 - -
BB Adamant Biotech B USD reinvestment 422.9800 +8.17% +22.67%
BB Adamant Biotech B CHF reinvestment 362.1800 +6.45% +33.47%
BB Adamant Biotech B EUR reinvestment 504.6600 +7.94% +49.33%

Performance

YTD  
+8.37%
6 Months  
+0.48%
1 Year  
+8.74%
3 Years  
+52.68%
5 Years  
+161.54%
Since start  
+330.50%
Year
2016
  -21.86%
2015  
+20.78%
2014  
+56.40%
2013  
+57.85%
2012  
+30.44%
2011
  -5.27%
2010  
+20.78%